Definium Therapeutics, Inc. ($DFTX)
Filing Information
| Accession Number | 0001193125-26-389890 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 14, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
125,000
Total Value
$0.00
P&L
+inf% (+$4,776,250.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Shares | โ | Sep 14, 2026 | Grant/Award | 125,000 | $0.00 | $0.00 | 362,133 | Direct | โ | View Details |